The association between cocaine use and treatment outcomes in patients receiving office-based buprenorphine/naloxone for the treatment of opioid dependence

American Journal on Addictions

Volumn 19, Issue 1, 2010, Pages 53-58

  Sullivan, Lynn E ^a   Moore, Brent A ^a   O'Connor, Patrick G ^a   Barry, Declan T ^a   Chawarski, Marek C ^a   Schottenfeld, Richard S ^a   Fiellin, David A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE PLUS NALOXONE; COCAINE; DRUG METABOLITE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG USE; EVALUATION; FEMALE; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; METABOLITE; OCCUPATIONAL HEALTH SERVICE; OPIATE ADDICTION; PRIMARY MEDICAL CARE; PSYCHOSOCIAL CARE; TREATMENT OUTCOME; URINALYSIS;

ADULT; BUPRENORPHINE; COCAINE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; NALOXONE; NARCOTIC ANTAGONISTS; OFFICE VISITS; OPIOID-RELATED DISORDERS; STREET DRUGS; TREATMENT OUTCOME;

EID: 77149125934     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1111/j.1521-0391.2009.00003.x     Document Type: Article

References (23)

1. Leri F, Bruneau J, Stewart J. Understanding polydrug use: Review of heroin and cocaine co-use. Addiction. 2003 98 : 7 22.
2. Hubbard RL, Craddock SG, Flynn PM, et al. Overview of 1-year follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychol Addict Behav. 1997 11 : 261 278.
3. Camacho LM, Bartholomew NG, Joe GW, et al. Gender, cocaine and during-treatment HIV risk reduction among injection opioid users in methadone maintenance. Drug Alcohol Depend. 1996 41 : 1 7.
4. Di Poggio AB, Fornal F, Paparelli A, et al. Comparison between heroin and heroin-cocaine polyabusers: A psychopathological study. Ann N Y Acad Sci. 2006 1074 : 438 445.
5. Grella CE, Anglin MD, Wugalter SE. Cocaine and crack use and HIV risk behaviors among high-risk methadone maintenance clients. Drug Alcohol Depend. 1995 37 : 15 21.
6. Grella CE, Anglin MD, Wugalter SE. Patterns and predictors of cocaine and crack use by clients in standard and enhanced methadone maintenance treatment. Am J Drug Alcohol Abuse. 1997 23 : 15 42.
7. Schottenfeld RS, Chawarski MC, Pakes JR, et al. Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence. Am J Psychiatry. 2005 162 : 340 349.
8. Maremmani I, Pani PP, Mellini A, et al. Alcohol and cocaine use and abuse among opioid addicts engaged in a methadone maintenance treatment program. J Addict Dis. 2007 26 : 61 70.
9. Williamson A, Darke S, Ross J, Teesson M. The effect of persistence of cocaine use on 12-month outcomes for the treatment of heroin dependence. Drug Alcohol Depend. 2006 81 : 293 300.
10. Fiellin DA, Pantalon MV, Pakes JP, et al. Treatment of heroin dependence with buprenorphine in primary care. Am J Drug Alcohol Abuse. 2002 28 : 231 241.
11. Johnson RE, Eissenberg T, Stitzer MI, et al. A placebo controlled clinical trial of buprenorphine as a treatment for opioid dependence. Drug Alcohol Depend. 1995 40 : 17 25.
12. Ling W, Charuvastra C, Collins JF, et al. Buprenorphine maintenance treatment of opiate dependence: A multicenter, randomized clinical trial. Addiction. 1998 93 : 475 486.
13. Fudala PJ, Bridge TP, Herbert S, et al. Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone. N Engl J Med. 2003 349 : 949 958.
14. Marsch LA, Stephens MA, Mudric T, et al. Predictors of outcome in LAAM, buprenorphine, and methadone treatment for opioid dependence. Exp Clin Psychopharmacol. 2005 13 : 293 302.
15. Fiellin DA, Pantalon MV, Chawarski MC, et al. Buprenorphine maintenance in primary care: A randomized controlled trial of counseling conditions and medication dispensing. N Engl J Med. 2006 355 : 365 374.
16. Sofuoglu M, Gonzalez G, Poling J, et al. Prediction of treatment outcome by baseline urine cocaine results and self-reported cocaine use for cocaine and opioid dependence. Am J Drug Alcohol Abuse. 2003 29 : 713 727.
17. Schottenfeld RS, Pakes J, O'Connor P, et al. Thrice-weekly versus daily buprenorphine maintenance. Biol Psychiatry. 2000 47 : 1072 1079.
18. Montoya ID, Gorelick DA, Preston KL, et al. Randomized trial of buprenorphine for treatment of concurrent opiate and cocaine dependence. Clin Pharmacol Ther. 2004 75 : 34 48.
19. McCance-Katz EF, Rainey PM, Moody DE : Effect of cocaine use on buprenorphine pharmacokinetics in humans. Am J Addict. DOI : 10.1111/j.1521-0391.2009.00001.x.
20. de Lima MS, de Oliveira Soares BG, Reisser AA, et al. Pharmacological treatment of cocaine dependence: A systematic review. Addiction. 2002 97 : 931 949.
21. Simpson DD, Joe GW, Fletcher BW, et al. A national evaluation of treatment outcomes for cocaine dependence. Arch Gen Psychiatry. 1999 56 : 507 514.
22. Crits-Christoph P, Siqueland L, Blaine J, et al. Psychosocial treatments for cocaine dependence: National Institute on Drug Abuse Collaborative Cocaine Treatment Study. Arch Gen Psychiatry. 1999 56 : 493 502.
23. Kosten T, Oliveto A, Feingold A, et al. Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients. Drug Alcohol Depend. 2003 70 : 315 325.